| Metric | PHM | RIVN |
|---|---|---|
| AI Score | 64 | 61 |
| Price | $129.65 | $16.81 |
| P/E Ratio | 13.19× | -6.43× |
| ROE | 17.1% | -79.9% |
| Revenue Growth YoY | — | — |
| Gross Margin | 24.5% | 7.5% |
| Debt / Equity | 0.18× | 1.04× |
| Dividend Yield | 0.8% | 0.0% |
| RSI (14) | 51.3 | 59.6 |
| Beta | 1.206 | 1.612 |
| Expected Upside | +1.2% | +0.3% |
PHM scores 64/100 (Buy) versus RIVN at 61/100 (Buy).
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
The committee is genuinely divided. Growth Analyst sees a compelling case — 4 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 15.6% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.